This cell line was used to measure the expression of the key prognostic markers including tyrosine‐protein kinase Kit (CD117) [23], VEGFR2, confirming their origin from a mast cell tumour and suitability for studying as targets for OVs. Here, KIT is linked to mast cell neoplasm.